UT Shield

, Filed Under: Lead Story

Peptide-Based Immunotherapy

We have developed a fully synthetic, targeted peptide-based immunotherapy for treating Non-small Cell Lung Cancer (Mol Ther. 2015 Jun;23(6):1092-1102).

Left image demonstrates tumor cells being destroyed by T cells
following treatment with peptide-based immunotherapy